Showing 3,121 - 3,140 results of 5,899 for search '"M.S."', query time: 0.07s Refine Results
  1. 3121

    Estrous Synchronization and Fixed-Time Artificial Insemination by Vitor R. G. Mercadante, Darren D. Henry, Francine M. Ciriaco, Pedro L. P. Fontes, Nicky Oosthuizen, G. Cliff Lamb

    Published 2016-04-01
    “…Mercadante, Darren D. Henry, Francine M. Ciriaco, Pedro L. P. Fontes, Nicky Oosthuizen, and G. …”
    Get full text
    Article
  2. 3122
  3. 3123
  4. 3124
  5. 3125
  6. 3126
  7. 3127
  8. 3128
  9. 3129
  10. 3130

    Hesperidoside abolishes dichlorvos-mediated neurotoxicity in rats by suppressing oxidative stress, acetylcholinesterase inhibition, and NF-κB-p65/p53/caspase-3-mediated apoptosis by Adio J. Akamo, Adetutu O. Ojelabi, Oluwatobi T. Somade, Iyabode A. Kehinde, Adewale M. Taiwo, Boluwatife A. Olagunju, Mushafau A. Akinsanya, Adedayo A. Adebisi, Tobi S. Adekunbi, Abiola F. Adenowo, Florence Anifowose, Olufemi M. Ajagun-Ogunleye, Ofem E. Eteng, Jacob K. Akintunde, Regina N. Ugbaja

    Published 2025-02-01
    “…Results: HESP intervention remarkably (p < 0.05) mitigated DDVP-potentiated augmentations in cerebral concentrations of H₂O₂, NO, and malondialdehyde; impaired DDVP-induced decrease in cerebral GSH, GST, SOD, catalase, glutathione peroxidase, and acetylcholinesterase; significantly (p < 0.05) suppressed DDVP-invoked upregulation of mRNA expression of NF-κB-p65, p53, BAX, caspase-3, and TNF-α; and significantly (p < 0.05) revoked DDVP-incited downregulation of interleukin-10. …”
    Get full text
    Article
  11. 3131
  12. 3132
  13. 3133
  14. 3134
  15. 3135
  16. 3136
  17. 3137

    Kidney disease among adults on tenofovir-based second-line antiretroviral therapy in Dar es Salaam, Tanzania by Sabina F. Mugusi, Grace A. Shayo, Philip G. Sasi, Lulu S. Fundikira, Eric A. Aris, Christopher R. Sudfeld, Ferdinand M. Mugusi

    Published 2025-01-01
    “…Patients were on second-line ART for a median of 49 [IQR: 25–73] months, and 60% received ATV/r. Low eGFR ( 90 mL/min per 1.73 m2) was found in 22% of patients, proportionately higher among patients on ATV/r compared to those on a lopinavir/ritonavir (LPV/r) (P  0.05). …”
    Get full text
    Article
  18. 3138
  19. 3139
  20. 3140